These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9755502)
41. Complete genome sequence analysis of Nocardia brasiliensis HUJEG-1 reveals a saprobic lifestyle and the genes needed for human pathogenesis. Vera-Cabrera L; Ortiz-Lopez R; Elizondo-Gonzalez R; Ocampo-Candiani J PLoS One; 2013; 8(6):e65425. PubMed ID: 23755230 [TBL] [Abstract][Full Text] [Related]
42. Antibiotic sensitivity patterns of actinomycetes isolated from patients of actinomycetoma. Chaudhuri BN; Maiti PK; Sil J Indian J Med Res; 1997 Apr; 105():162-6. PubMed ID: 9145598 [TBL] [Abstract][Full Text] [Related]
43. In vitro activities of new antimicrobials against Nocardia brasiliensis. Vera-Cabrera L; Gonzalez E; Choi SH; Welsh O Antimicrob Agents Chemother; 2004 Feb; 48(2):602-4. PubMed ID: 14742215 [TBL] [Abstract][Full Text] [Related]
44. Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China. Wei M; Wang P; Qu J; Li R; Liu Y; Gu L; Yang C J Glob Antimicrob Resist; 2017 Dec; 11():183-187. PubMed ID: 28870771 [TBL] [Abstract][Full Text] [Related]
45. [Mycetoma in northern Argentina]. Biagini RE; Martínez TE; Museli A; Sarmiento Villa H Med Cutan Ibero Lat Am; 1983; 11(6):431-6. PubMed ID: 6366400 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice. Chacon-Moreno BE; Welsh O; Cavazos-Rocha N; de la Luz Salazar-Cavazos M; Garza-Lozano HG; Said-Fernandez S; Ocampo-Candiani J; Vera-Cabrera L Antimicrob Agents Chemother; 2009 Jan; 53(1):295-7. PubMed ID: 18852277 [TBL] [Abstract][Full Text] [Related]
47. Diaminodiphenyl-sulphone: in vitro activity alone and in combination with other antimicrobials against 30 strains of Nocardia brasiliensis. Gonzalez-Benavides N; Vera-Cabrera L; Sanchez-Meza E; Ocampo-Candiani J; Welsh O J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e395-e396. PubMed ID: 31063602 [No Abstract] [Full Text] [Related]
48. Molecular identification and antimicrobial susceptibility of Nocardia spp. isolated from bovine mastitis in Brazil. Condas LA; Ribeiro MG; Yazawa K; de Vargas AP; Salerno T; Giuffrida R; Langoni H; Melville PA; Biesdorf S; Matsuzawa T; Gonoi T; Kastelic JP; Barkema HW Vet Microbiol; 2013 Dec; 167(3-4):708-12. PubMed ID: 24060098 [TBL] [Abstract][Full Text] [Related]
49. [In vitro sensitivity of Nocardia brasiliensis to various antibiotics and therapeutic drugs]. Minami PS; Junqueira Martins JB; Parra DS Rev Farm Bioquim Univ Sao Paulo; 1974; 12(2):147-63. PubMed ID: 4468453 [No Abstract] [Full Text] [Related]
50. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503 [TBL] [Abstract][Full Text] [Related]
51. Construction of a Nocardia brasiliensis fluorescent plasmid to study Actinomycetoma pathogenicity. Salinas-Carmona MC; Rocha-Pizaña MR Plasmid; 2011 Jan; 65(1):25-31. PubMed ID: 20875450 [TBL] [Abstract][Full Text] [Related]
52. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995. Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980 [TBL] [Abstract][Full Text] [Related]
53. Susceptibility testing of Nocardia species for the clinical laboratory. Wallace RJ; Steele LC Diagn Microbiol Infect Dis; 1988 Mar; 9(3):155-66. PubMed ID: 3293892 [TBL] [Abstract][Full Text] [Related]
54. In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp. Yazawa K; Mikami Y; Ohashi S; Miyaji M; Ichihara Y; Nishimura C J Antimicrob Chemother; 1992 Feb; 29(2):169-72. PubMed ID: 1506332 [TBL] [Abstract][Full Text] [Related]
55. Clinical isolates of Nocardia brasiliensis from Japan exhibit variable susceptibility to the antibiotic imipenem. Kageyama A; Hoshino Y; Watanabe M; Yazawa K; Mikami Y Mycopathologia; 2004 Oct; 158(3):275-8. PubMed ID: 15702268 [TBL] [Abstract][Full Text] [Related]
56. New species-related MIC breakpoints for early detection of development of resistance among gram-negative bacteria in Swedish intensive care units. Hanberger H; Nilsson LE; Claesson B; Kärnell A; Larsson P; Rylander M; Svensson E; Sörberg M; Sörén L J Antimicrob Chemother; 1999 Nov; 44(5):611-9. PubMed ID: 10552977 [TBL] [Abstract][Full Text] [Related]
57. In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis. González-Martínez NA; Lozano-Garza HG; Castro-Garza J; De Osio-Cortez A; Vargas-Villarreal J; Cavazos-Rocha N; Ocampo-Candiani J; Makarov V; Cole ST; Vera-Cabrera L PLoS Negl Trop Dis; 2015; 9(10):e0004022. PubMed ID: 26474057 [TBL] [Abstract][Full Text] [Related]
58. Susceptibility in vitro of Nocardia species to antimicrobial agents. Southern PM; Kutscher AE; Ragsdale R; Luttrell B Diagn Microbiol Infect Dis; 1987 Oct; 8(2):119-22. PubMed ID: 3427888 [TBL] [Abstract][Full Text] [Related]
59. In-vitro activity of flomoxef, a new oxacephem group antibiotic, against Nocardia in comparison with other cephalosporins. Yazawa K; Mikami Y; Uno J; Otozai K; Arai T J Antimicrob Chemother; 1989 Dec; 24(6):921-5. PubMed ID: 2621177 [TBL] [Abstract][Full Text] [Related]
60. Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017. Huang L; Chen X; Xu H; Sun L; Li C; Guo W; Xiang L; Luo G; Cui Y; Lu B Diagn Microbiol Infect Dis; 2019 Jun; 94(2):165-172. PubMed ID: 30679058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]